MaxQ Medical Raises $31.5 Million for Prostate Care Platform
MaxQ Medical has closed a $31.5 million Series A financing to advance its prostate care platform, the company announced in a press release. The round was led by Atlantic Blue Ventures, S3 Ventures, and Olympus Innovation Ventures, with participation from existing investor Hillside Capital.
The company said the funds will be used to expand its team and move forward with its clinical program. MaxQ Medical is developing a transurethral system that combines advanced imaging with therapy in one procedure for prostate care.
The first planned indication is benign prostatic hyperplasia. MaxQ Medical also plans to expand the platform into focal therapy for prostate cancer and later into prostate diagnostics, including biopsy and tumor mapping.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 13 Stryker Plans $400 Million CMR Surgical Investment Oct 13 Suvoda Expands Sofia to All New RTSM and eCOA Trials Oct 13 HealthpointCapital Invests in Surgical Software Company Ospitek Oct 13 Prologue Medicines names Stephen Harrison chief scientific officer Oct 13 symplr Survey Finds Nearly Half of Hospital Operations Remain ManualMore from Funding
Oct 13 Mogul Raises $15.5 Million for AI Real Estate Platform Oct 13 Aatmunn Secures Up to $8 Million to Expand SPANR Oct 13 AppWork Acquires Paraspot AI for Video Property Inspections Oct 13 Monopulse Raises Over €2 Million for Electronic Warfare Resistant Drones Oct 13 HyLight Raises €13 Million for Hydrogen Airship InspectionsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
NAVER D2SF Backs ImpriMed in $10 Million Bridge Round
Basecamp Research Raises $140 Million for AI Designed Therapeutics
Healthleap Raises $38 Million for Hospital Risk Screening AI
Sensydia Raises More Than $6 Million for AI Cardiac System
Ayble Health Raises $16 Million for Virtual Digestive Care
Daily AI Brief: the AI news that matters, in your inbox.